At the recent International Conference on Alzheimer’s and Parkinson’s Diseases in Gothenburg, Sweden, researchers discussed how they might hone antibodies and vaccination strategies to become ...

Antibodies have proven to be an excellent ... The future of all small single domains is clearly to provide new binding specificities, particularly to targets inaccessible to conventional antigen ...

Allen Guo, CEO "We are excited to present our pre-clinical findings at the AACR, showcasing the significant potential of our CD3 agonistic single-domain antibody," said Allen Guo, CEO.

Originally derived from camelid heavy chain antibodies, single domain or VHH antibodies can bind epitopes that are inaccessible to conventional monoclonal antibodies due to their small size. Because ...

Single domain antibodies (AKA nanobodies), the variable domains of some camelid antibodies, have interesting properties, including high production yields and stability but also the ability to bind ...

The Australian company is betting the radionuclide could be an option for patients with HER2-expressing solid tumors who can't tolerate other treatments.

Valour Bio has been established as a wholly owned subsidiary of Valerio Therapeutics to focus on discovering single domain antibodies (sdAbs) as drug and radio conjugates, bispecific T-cell ...

Single domain antibodies (sdAb) consist of a single monomeric variable antibody domain, and the use of sdAb is projected to increase significantly over the coming years owing to various factors ...